at the CNIO

Tag: diabetes (Page 2 of 10)

¿Qué controla nuestra hambre?

Guadalupe sabio explica que “cuando estamos en ayunas, la disminución de los niveles de glucosa en sangre contribuye a desencadenar el hambre. Cuando esto sucede se activa el sistema nervioso simpático, lo que puede aumentar la liberación de glucagón y cortisol, hormonas que promueven la liberación de glucosa almacenada en el hígado para mantener los niveles de azúcar en sangre. Además, el sistema digestivo secreta diversas hormonas que estimulan el apetito, como la grelina, que se libera cuando el estómago está vacío”.

Targeting ERK3/MK5 complex for treatment of obesity and diabetes

Angel Loza-Valdes, Rabih El-Merahbi, Toufic Kassouf, Agnieszka Demczuk, Saskia Reuter, Jonathan Trujillo Viera, Till Karwen, Minhe Noh, Mona C. Löffler, Rafael Romero-Becerra, Jorge L. Torres, Miguel Marcos, Guadalupe Sabio, Urszula Wojda & Grzegorz Sumar.

Kinases represent one of the largest druggable families of proteins. Importantly, many kinases are aberrantly activated/de-activated in multiple organs during obesity, which contributes to the development of diabetes and associated diseases. Previous results indicate that the complex between Extracellular-regulated kinase 3 (ERK3) and Mitogen-Activated Protein Kinase (MAPK)-activated protein kinase 5 (MK5) suppresses energy dissipation and promotes fatty acids (FAs) output in adipose tissue and, therefore promotes obesity and diabetes. However, the therapeutic potential of targeting this complex at the systemic level has not been fully explored.

MK5 mRNA levels in subcutaneous adipose tissue in healthy lean subjects obese subjects.

Here we applied a translational approach to target the ERK3/MK5 complex in mice. Importantly, deletion of ERK3 in the whole body or administration of MK5-specific inhibitor protects against obesity and promotes insulin sensitivity. Finally, we show that the expression of ERK3 and MK5 correlates with the degree of obesity and that ERK3/MK5 complex regulates energy dissipation in human adipocytes.

Altogether, we demonstrate that ERK3/MK5 complex can be targeted in vivo to preserve metabolic health and combat obesity and diabetes.

« Older posts Newer posts »

© 2024 Sabio lab

Theme by Anders NorénUp ↑